Effects of N-acetylcysteine on nitroglycerin-induced relaxation and protein phosphorylation of porcine coronary arteries

Heart and Vessels

Volumn 13, Issue 6, 1999, Pages 263-268

  Tate, Yasuo ^a   Kawasaki, Ken Ichi ^a   Ishibashi, Shojiro ^a   Ikeda, Uichi ^a   Shimada, Kazuyuki ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary artery; Desmin; Nitroglycerin; Phosphorylation; Tolerance

Indexed keywords

ACETYLCYSTEINE; DESMIN; GLYCERYL TRINITRATE; HISTAMINE; MYOSIN LIGHT CHAIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DILATATION; INTERMEDIATE FILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE RELAXATION; SWINE; VASCULAR SMOOTH MUSCLE;

EID: 0032844019     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03257230     Document Type: Article

References (32)

1. Needleman P, Johnson EM Jr (1973) Mechanism of tolerance development to organic nitrates. J Pharmacol Exp Ther 184:706-715
2. Needleman P, Jakschik B, Johnson EM Jr (1973) Sulfhydryl requirement for relaxation of vascular smooth muscle. J Pharmacol Exp Ther 187:324-331
3. Axelsson KL, Andersson RGG (1983) Tolerance towards nitroglycerin induced in vivo, is correlated to reduced cGMP response and an alteration in cGMP turnover. Eur J Pharmacol 88:71-79
4. Keith RA, Burkman AM, Sokoloski TD, Fertel RH (1982) Vascular tolerance to nitroglycerin and cyclic GMP generation in rat aortic smooth muscle. J Pharmacol Exp Ther 221:525-531
5. Awan NA, Evenson MK, Needham KE, Win A, Mason DT (1981) Efficacy of oral angiotensin-converting enzyme inhibition with captopril therapy in severe chronic normotensive congestive heart failure. Am Heart J 101:22-31
6. i and uncoupling stress from myosin phosphorylation. Am J Physiol 263:C461-C467
7. Mehta JL, Lawson DL, Nichols WW (1991) Recovery of vascular smooth muscle relaxation from nitroglycerin-induced tolerance following a drug-free interval. A time-course in vitro study. Biochem Pharmacol 41:743-747.
8. 2+ concentrations measured with fura-1. Br J Pharmacol 98:469-482
9. Ishibashi S, Kawasaki K, Tate Y, Ihara T, Shimada K (1995) Nitroglycerin inhibits the phosphorylation of intermediate filament proteins rather than myosin light chain on porcine coronary artery sustained contraction. Experientia 51:980-985
10. 2+ movement of porcine coronary arteries. Atherosclerosis 130:113-119
11. Ohkawa F, Ikeda U, Kawasaki K, Kusano E, Igarashi M, Shimada K (1994) Inhibitory effect of interleukin 6 on vascular smooth muscle contraction. Am J Physiol 266:H898-H902.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
13. O'Farrell PH (1975) High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250:4007-4021
14. Ignarro LJ (1989) Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res 65:1-21
15. Needleman P (1970) Tolerance to the vascular effects of glyceryl trinitrate. J Pharmacol Exp Ther 171:98-102
16. Abrams J (1991) Interactions between organic nitrates and thiol groups. Am J Med 91(3C):106S-112S
17. Chong S, Fung HL (1991) Biochemical and pharmacological interactions between nitroglycerin and thiols. Effects of thiol structure on nitric oxide generation and tolerance reversal. Biochem Pharmacol 42:1433-1439
18. Dupuis J, Lalonde G, Lemieux R, Rouleau JL (1990) Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteine. J Am Coll Cardiol 16:923-931
19. Kukovetz WR, Holzmann S (1990) Mechanisms of nitrate-induced vasodilatation and tolerance. Eur J Clin Pharmacol 38:S9-S14
20. + channel-dependent and cyclic GMP-dependent components in a single vascular preparation. J Cardiovasc Pharmacol 17:903-912
21. Horowitz JD, Henry CA, Syrjanen ML, Louis WJ, Fish RD, Smith TW, Antman EM (1988) Combined use of nitroglycerine and N-acetyl-cysteine in the management of unstable angina pectoris. Circulation 77:787-794
22. Henry P, Horowitz JD, Louis WJ (1989) Determinants of in vitro nitroglycerine tolerance induction and reversal: influence of dose regimen, nitrate-free period and sulfhydryl supplementation. J Cardiovasc Pharmacol 14:31-37
23. Torresi J, Horowitz JD, Dusting GJ (1985) Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine. J Cardiovasc Pharmacol 7:777-783
24. May DC, Popma JJ, Black WH, Schaefer S, Lee HR, Levine BD, Hills LD (1987) In vivo induction and reversal of nitroglycerin tolerance in human coronary arteries. N Engl J Med 317:805-809
25. Packer M, Lee WH, Kessler PD, Gottlieb SS, Medina N, Yushak M (1987) Prevention and reversal of nitrate tolerance in patients with congestive heart failure. N Engl J Med 317:799-804
26. Matsuzaki T, Sakanashi M (1992) Comparison of the development of tolerance to nitroglycerin in aortic preparations isolated from non-diabetic and diabetic rats. Heart Vessels 7:1-7
27. Gruetter CA, Lemke SM (1985) Dissociation of cysteine and glutathione levels from nitroglycerin-induced relaxation. Eur J Pharmacol 111:85-95
28. Gruetter CA, Lemke SM (1986) Effects of sulfhydryl reagents on nitroglycerin-induced relaxation of bovine coronary artery. Can J Physiol Pharmacol 64:1395-1401
29. Axelsson KL, Andersson RGG, Wikberg JES (1982) Vascular smooth muscle relaxation by nitro compounds. Reduced relaxation and cGMP elevation in tolerance vessels and reversal of tolerance by dithiothreitol. Acta Pharmacol Toxicol 50:350-357
30. Lazarides E (1982) Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins. Annu Rev Biochem 51:219-250
31. Schelling JL, Lasagna L (1967) A study of cross-tolerance to circulatory effects of organic nitrates. Clin Pharmacol Ther 8:256-260
32. Bogaert MG, De Schaepdryver AF (1968) Tolerance towards glyceryl-trinitrate (trinitrin) in dogs. Arch Int Pharmacodyn Ther 171:221-224